Welcome to the official web site for the International Workhops on Waldenstrom's Macroglobulinemia
The Second International Workshop on Waldenstrom's Macroglobulinemia
*Overview* Program Abstracts Media

Learn about our upcoming and previous conferences

Stockholm 2008
Kos 2007
Paris 2004
Athens 2002
Washington 2000

Media and Abstracts
Home
Links

Program of the 2nd International Workshop on Waldenström's macroglobulinemia

September 26-30, 2002
Athens, Greece

Download the entire program as a word document
Choose a Day
1 - 2 - 3 - 4

Saturday, September 28, 2002 Astir Palace

7:00 AM

Breakfast

Session VI Report of Consensus Panel Two
Co-Chairs: Dr. Kyle (USA) and Dr. LeBlond (France)

8:00-9:30

Dr. LeBlond (France)

Report of Consensus Panel Two on Prognostic Markers and Criteria to Treat WM

Dr. Kyle (USA)

Discussion and Consensus Summary

9:30-9:45

Session Break

Session VII Therapeutics in WM: Alkylator agents and nucleoside analogues
Chair: Dr. Lister (UK)

9:45 AM

Dr. LeBlond (France)

Fludarabine therapy in WM

10:00 AM

Dr. Weber (USA)

Cladribine therapy in WM

10:15 AM

Dr. Rummel (Germany)*

Combination nucleoside analogue and novel alkylator based therapies for WM

10:30 AM

Dr. Lister (UK)

Defining the use of alkylator agents and nucleoside analogues in WM

10:45-11:15

Dr. Lister (UK)

Panel Discussion

11:15-1:00

Lunch

Session VIII Therapeutics in WM: Monoclonal Antibodies
Chair: Dr. Kimby (Sweden)

1:00 PM

Dr. Treon (USA)

Clinical and laboratory studies on the use of monoclonal antibody therapy in WM

1:15 PM

Dr. Kimby (Sweden)

Enhancing Rituximab efficacy in WM

1:30 PM

Dr. Cesano (USA)

CD22 directed serotherapy of WM

1:45 PM

Dr. Grewal (USA)

CD40 directed serotherapy of WM

2:00 PM

Dr. Crowley-Nowick (USA)

CD52 directed serotherapy of WM

2:15 PM

Dr. Byrd (USA)

Novel antibodies for the therapy of WM

2:30 PM

Dr. Emmanouilides (USA)

Radioimmunotherapy of WM

2:45-3:15

Dr. Kimby (Sweden)

Panel Discussion

3:15-3:45

Session Break

Session IX Therapeutics in WM: Thalidomide
Chair: Dr. Coleman (USA)

3:45 PM

Dr. Greipp (USA)

Bone marrow angiogenesis in WM

4:00 PM

Dr. Dimopoulos (Greece)

Thalidomide-based therapy of WM

4:15 PM

Dr. Coleman (USA)

Biaxin, Low-dose Thalidomide, and Dexamethasone (BLT-D) in WM

4:30 PM

Dr. Zeldis (USA)

Thalidomide analogues and other novel agents for the treatment of plasma cell disorders

4:45-5:00

Dr. Coleman (USA)

Panel Discussion

Session X Therapeutics in WM: Transplant Therapy
Chair: Dr. Munshi (USA)

5:00 PM

Dr. Munshi (USA)

High dose chemotherapy with stem cell transplantation in WM

5:15 PM

Dr. Anagnostopoulos (USA)

Autologous stem cell transplantion in WM

5:30 PM

Dr. Tournilhac (France)*

Transplantation in WM: The French Experience

5:45 PM

Dr. Giralt (USA)

Allogeneic stem cell transplantion in WM

6:00 PM

Dr. Maloney (USA)

Non-myeloablative allogeneic transplantation for WM

6:15-6:45

Dr. Munshi (USA)

Panel Discussion

7:30 PM

Bus Departures for Dinner Reception

*Young Investigator Fellowship Award Recipient
Sponsored by the International Waldenström's Macroglobulinemia Foundation

# Smokler Research Grant recipient
Sponsored by the RFW, Ltd.

<< Friday, September 27 | Sunday, September 29 >>

Contact us | Site Map | Workshop News